Literature DB >> 12525656

Noninvasive detection of new simian immunodeficiency virus lineages in captive sooty mangabeys: ability to amplify virion RNA from fecal samples correlates with viral load in plasma.

Binhua Ling1, Mario L Santiago, Sreelatha Meleth, Bobby Gormus, Harold M McClure, Cristian Apetrei, Beatrice H Hahn, Preston A Marx.   

Abstract

The sooty mangabey (SM) (Cercocebus atys) is the natural host of a simian immunodeficiency virus, termed SIVsm, which gave rise to human immunodeficiency virus type 2. Data on the geographic distribution, prevalence, and genetic diversity of SIVsm in the wild remains limited. To address this issue, noninvasive strategies based on screening SM fecal and urine specimens for SIVsm-specific antibodies and virion RNA (vRNA) were developed, and the results were correlated with viral loads in plasma. Twenty-three SIVsm-infected and 27 uninfected SMs were evaluated. Time-matched urine, fecal and plasma samples were collected over a 2-month period from 16 captive naturally infected SMs. The remaining 7 infected and 27 uninfected SMs were sampled once. Each specimen was subjected to enhanced chemiluminescence-Western blot analysis and nested reverse transcriptase (RT) PCR. The results showed that urine was highly sensitive (96%) and specific (100%) for detection of SIVsm antibodies, while fecal detection was much less sensitive (16%). Conversely, vRNA detection was more sensitive in feces (50%) than in urine (2%) samples. Fecal-vRNA detection correlated with viral loads in plasma (P < 0.002). SMs with detectable fecal vRNA had a mean viral load in plasma of 458,006 copies/ml, while those with undetectable fecal vRNA had a mean viral load in plasma of 29,428 copies/ml. Moreover, for every log increase in the viral load in plasma, the odds of detecting virus in fecal samples increased 87-fold. Genetic diversity of SIVsm in the SM colony was characterized by sequencing partial gag (846 bp) and gp43 (439 bp) fragments. Surprisingly, four new SIVsm lineages were identified, two of which were initially detected by fecal RT-PCR. This study documents the suitability of noninvasive methods for the detection and molecular characterization of new SIV variants. These assays will be useful for studying the phylogeny and epidemiology of SIVsm infections in the wild, and they hold promise as tools for investigating natural SIV infections in endangered nonhuman primates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525656      PMCID: PMC140942          DOI: 10.1128/jvi.77.3.2214-2226.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Relationship of CD4+ T cell counts and HIV type 1 viral loads in untreated, infected adolescents. Adolescent Medicine HIV/AIDS Research Network.

Authors:  C A Holland; J H Ellenberg; C M Wilson; S D Douglas; D C Futterman; L A Kingsley; A B Moscicki
Journal:  AIDS Res Hum Retroviruses       Date:  2000-07-01       Impact factor: 2.205

2.  Wide range of viral load in healthy african green monkeys naturally infected with simian immunodeficiency virus.

Authors:  S Goldstein; I Ourmanov; C R Brown; B E Beer; W R Elkins; R Plishka; A Buckler-White; V M Hirsch
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Simian immunodeficiency virus from mandrill (Mandrillus sphinx) SIVmnd experimentally infects human and nonhuman primate cells.

Authors:  V Poaty-Mavoungou; R Onanga; I Bedjabaga; E Mavoungou
Journal:  Microbes Infect       Date:  2001-07       Impact factor: 2.700

4.  Wild Mandrillus sphinx are carriers of two types of lentivirus.

Authors:  S Souquière; F Bibollet-Ruche; D L Robertson; M Makuwa; C Apetrei; R Onanga; C Kornfeld; J C Plantier; F Gao; K Abernethy; L J White; W Karesh; P Telfer; E J Wickings; P Mauclère; P A Marx; F Barré-Sinoussi; B H Hahn; M C Müller-Trutwin; F Simon
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france.

Authors:  F Damond; C Apetrei; D L Robertson; S Souquière; A Leprêtre; S Matheron; J C Plantier; F Brun-Vézinet; F Simon
Journal:  Virology       Date:  2001-02-01       Impact factor: 3.616

6.  Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses.

Authors:  F Simon; S Souquière; F Damond; A Kfutwah; M Makuwa; E Leroy; P Rouquet; J L Berthier; J Rigoulet; A Lecu; P T Telfer; I Pandrea; J C Plantier; F Barré-Sinoussi; P Roques; M C Müller-Trutwin; C Apetrei
Journal:  AIDS Res Hum Retroviruses       Date:  2001-07-01       Impact factor: 2.205

7.  Characterization of a novel simian immunodeficiency virus from guereza colobus monkeys (Colobus guereza) in Cameroon: a new lineage in the nonhuman primate lentivirus family.

Authors:  V Courgnaud; X Pourrut; F Bibollet-Ruche; E Mpoudi-Ngole; A Bourgeois; E Delaporte; M Peeters
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  Natural infection of wild-born mandrills (Mandrillus sphinx) with two different types of simian immunodeficiency virus.

Authors:  J Takehisa; Y Harada; N Ndembi; I Mboudjeka; Y Taniguchi; C Ngansop; S Kuate; L Zekeng; K Ibuki; T Shimada; B Bikandou; Y Yamaguchi-Kabata; T Miura; M Ikeda; H Ichimura; L Kaptué; M Hayami
Journal:  AIDS Res Hum Retroviruses       Date:  2001-08-10       Impact factor: 2.205

9.  Urine antibody tests: new insights into the dynamics of HIV-1 infection.

Authors:  H B Urnovitz; J C Sturge; T D Gottfried; W H Murphy
Journal:  Clin Chem       Date:  1999-09       Impact factor: 8.327

10.  Relative resistance in the development of T cell anergy in CD4+ T cells from simian immunodeficiency virus disease-resistant sooty mangabeys.

Authors:  P Bostik; A E Mayne; F Villinger; K P Greenberg; J D Powell; A A Ansari
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

View more
  23 in total

1.  New simian immunodeficiency virus infecting De Brazza's monkeys (Cercopithecus neglectus): evidence for a cercopithecus monkey virus clade.

Authors:  Frederic Bibollet-Ruche; Elizabeth Bailes; Feng Gao; Xavier Pourrut; Katrina L Barlow; Jonathan P Clewley; Jason M Mwenda; Daudi K Langat; Gerald K Chege; Harold M McClure; Eitel Mpoudi-Ngole; Eric Delaporte; Martine Peeters; George M Shaw; Paul M Sharp; Beatrice H Hahn
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

2.  Antiviral antibodies and T cells are present in the foreskin of simian immunodeficiency virus-infected rhesus macaques.

Authors:  Kristina Rothaeusler; Zhong-Min Ma; Huma Qureshi; Timothy D Carroll; Tracy Rourke; Michael B McChesney; Christopher J Miller
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Lack of Evidence of Simian Immunodeficiency Virus Infection Among Nonhuman Primates in Taï National Park, Côte d'Ivoire: Limitations of Noninvasive Methods and SIV Diagnostic Tools for Studies of Primate Retroviruses.

Authors:  Sabrina Locatelli; Amy D Roeder; Michael W Bruford; Ronald Noë; Eric Delaporte; Martine Peeters
Journal:  Int J Primatol       Date:  2011-04       Impact factor: 2.264

4.  Molecular epidemiology of simian immunodeficiency virus SIVsm in U.S. primate centers unravels the origin of SIVmac and SIVstm.

Authors:  Cristian Apetrei; Amitinder Kaur; Nicholas W Lerche; Michael Metzger; Ivona Pandrea; Johnny Hardcastle; Shelley Falkenstein; Rudolf Bohm; Jeffrey Koehler; Vicki Traina-Dorge; Tessa Williams; Silvija Staprans; Gail Plauche; Ronald S Veazey; Harold McClure; Andrew A Lackner; Bobby Gormus; David L Robertson; Preston A Marx
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  High prevalence, coinfection rate, and genetic diversity of retroviruses in wild red colobus monkeys (Piliocolobus badius badius) in Tai National Park, Cote d'Ivoire.

Authors:  Siv Aina J Leendertz; Sandra Junglen; Claudia Hedemann; Adeelia Goffe; Sebastien Calvignac; Christophe Boesch; Fabian H Leendertz
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

6.  Simian immunodeficiency virus SIVagm.sab infection of Caribbean African green monkeys: a new model for the study of SIV pathogenesis in natural hosts.

Authors:  Ivona Pandrea; Cristian Apetrei; Jason Dufour; Nora Dillon; Joseph Barbercheck; Michael Metzger; Béatrice Jacquelin; Rudolf Bohm; Preston A Marx; Françoise Barre-Sinoussi; Vanessa M Hirsch; Michaela C Müller-Trutwin; Andrew A Lackner; Ronald S Veazey
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 7.  Going wild: lessons from naturally occurring T-lymphotropic lentiviruses.

Authors:  Sue VandeWoude; Cristian Apetrei
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

8.  Direct inoculation of simian immunodeficiency virus from sooty mangabeys in black mangabeys (Lophocebus aterrimus): first evidence of AIDS in a heterologous African species and different pathologic outcomes of experimental infection.

Authors:  Cristian Apetrei; Bobby Gormus; Ivona Pandrea; Michael Metzger; Peter ten Haaft; Louis N Martin; Rudolf Bohm; Xavier Alvarez; Gerrit Koopman; Michael Murphey-Corb; Ronald S Veazey; Andrew A Lackner; Gary Baskin; Jonathan Heeney; Preston A Marx
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

9.  Classic AIDS in a sooty mangabey after an 18-year natural infection.

Authors:  Binhua Ling; Cristian Apetrei; Ivona Pandrea; Ronald S Veazey; Andrew A Lackner; Bobby Gormus; Preston A Marx
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Eastern chimpanzees, but not bonobos, represent a simian immunodeficiency virus reservoir.

Authors:  Yingying Li; Jean-Bosco Ndjango; Gerald H Learn; Miguel A Ramirez; Brandon F Keele; Frederic Bibollet-Ruche; Weimin Liu; Juliet L Easlick; Julie M Decker; Rebecca S Rudicell; Bila-Isia Inogwabini; Steve Ahuka-Mundeke; Fabian H Leendertz; Vernon Reynolds; Martin N Muller; Rebecca L Chancellor; Aaron S Rundus; Nicole Simmons; Michael Worobey; George M Shaw; Martine Peeters; Paul M Sharp; Beatrice H Hahn
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.